Liver Surgery Unit, Digestive Surgery Division, Department of Gastroenterology, University of São Paulo School of Medicine, Rua Dr. Enéas de Carvalho Aguiar, 255-9º Andar-sala 9025, São Paulo, SP, CEP 05403-900, Brazil.
Digestive Surgery Unit, Diaconesses Croix Saint Simon Hospital, 125, Rue d'Avron, 75020, Paris, France.
BMC Surg. 2020 Oct 30;20(1):260. doi: 10.1186/s12893-020-00919-0.
Minimally invasive liver resections (MILRs) have been increasingly performed in recent years. However, the majority of MILRs are actually minor or limited resections of peripheral lesions. Due to the technical complexity major hepatectomies remain challenging for minimally invasive surgery. The aim of this study was to compare the short and long-term outcomes of patients undergoing minimally invasive right hepatectomies (MIRHs) with contemporary patients undergoing open right hepatectomies (ORHs) METHODS: Consecutive patients submitted to anatomic right hepatectomies between January 2013 and December 2018 in two tertiary referral centers were studied. Study groups were compared on an intention-to-treat basis after propensity score matching (PSM). Overall survival (OS) analyses were performed for the entire cohort and specific etiologies subgroups RESULTS: During study period 178 right hepatectomies were performed. After matching, 37 patients were included in MIRH group and 60 in ORH group. The groups were homogenous for all baseline characteristics. MIRHs had significant lower blood loss (400 ml vs. 500 ml, P = 0.01), lower rate of minor complications (13.5% vs. 35%, P = 0.03) and larger resection margins (10 mm vs. 5 mm, P = 0.03) when compared to ORHs. Additionally, a non-significant decrease in hospital stay (ORH 9 days vs. MIRH 7 days, P = 0.09) was observed. No differences regarding the use of Pringle's maneuver, operative time, overall morbidity or perioperative mortality were observed. OS was similar between the groups (P = 0.13). Similarly, no difference in OS was found in subgroups of patients with primary liver tumors (P = 0.09) and liver metastasis (P = 0.80).
MIRHs are feasible and safe in experienced hands. Minimally invasive approach was associated with less blood loss, a significant reduction in minor perioperative complications, and did not negatively affect long-term outcomes.
近年来,微创肝切除术(MILRs)的应用日益增多。然而,大多数 MILRs实际上是外周病变的小或有限切除。由于技术的复杂性,对于微创手术来说,大肝切除术仍然具有挑战性。本研究旨在比较接受微创右肝切除术(MIRHs)的患者与同期接受开腹右肝切除术(ORHs)的患者的短期和长期结果。
研究连续纳入了 2013 年 1 月至 2018 年 12 月在两个三级转诊中心接受解剖性右肝切除术的患者。采用倾向评分匹配(PSM)后,按意向治疗原则对两组进行比较。对整个队列和特定病因亚组进行总生存(OS)分析。
研究期间共进行了 178 例右肝切除术。匹配后,MIRH 组纳入 37 例,ORH 组纳入 60 例。两组在所有基线特征方面均具有同质性。与 ORH 相比,MIRH 组的术中出血量显著较少(400ml 比 500ml,P=0.01),较小的并发症发生率(13.5%比 35%,P=0.03)和更大的切除边缘(10mm 比 5mm,P=0.03)。此外,住院时间有非显著缩短(ORH 9 天比 MIRH 7 天,P=0.09)。两组在使用普雷尔氏手法、手术时间、总发病率或围手术期死亡率方面无差异。两组患者的 OS 相似(P=0.13)。同样,在原发性肝肿瘤(P=0.09)和肝转移瘤(P=0.80)患者亚组中,OS 无差异。
在经验丰富的医生手中,MIRHs 是可行和安全的。微创方法与较少的术中出血量、显著减少的围手术期小并发症相关,并且不会对长期结果产生负面影响。